Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Cardiovascular effects of preeclampsia
Smitha Neerukonda1, Farnoosh Shariati2, Taylor Hart1
1John Ochsner Heart and Vascular Institute.
Women with preeclampsia face significantly increased cardiovascular risks, including heart attack, stroke, and heart failure. Early detection and management by a preventive cardiologist are crucial for these high-risk patients.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Public Health
Background:
- Preeclampsia affects 3-5% of first pregnancies and 15% of subsequent pregnancies.
- Preeclampsia is a serious pregnancy complication with long-term health implications.
Purpose of the Study:
- To review the evidence linking preeclampsia to increased cardiovascular risk.
- To highlight the long-term cardiovascular health concerns for women with a history of preeclampsia.
Main Methods:
- Systematic review of existing literature.
- Analysis of epidemiological data and clinical studies.
Main Results:
- Women with preeclampsia have a two-fold higher risk of coronary artery disease, stroke, and death.
- A four-fold increased risk of heart failure is observed in women with preeclampsia.
- Early-onset preeclampsia is associated with greater cardiovascular risk than later onset.
Conclusions:
- Preeclampsia significantly elevates long-term cardiovascular disease risk.
- Shared risk factors for preeclampsia and cardiovascular disease include obesity, metabolic abnormalities, and endothelial dysfunction.
- Regular screening by a preventive cardiologist is recommended for women with a history of preeclampsia.
More Related Videos
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hormonal Regulation
Hypertension II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection

